论文部分内容阅读
目的了解不同糖代谢水平人群恶性肿瘤患病情况。方法采用分层整群抽样方法,对20岁及以上当地常住居民进行糖尿病筛查。利用慢性病监测信息系统和区域卫生信息平台,回顾性收集恶性肿瘤患病信息。结果共调查10 504人,新检出糖尿病702人,检出率为6.68%;恶性肿瘤患病89人,患病率为8.47‰。正常血糖、糖尿病前期和糖尿病人群的恶性肿瘤患病率差异无统计学意义(P>0.05)。恶性肿瘤患者的空腹血糖平均为(5.14±0.65)mmol/L,糖耐量2 h血糖平均为(6.78±2.66)mmol/L。65岁及以上老年人恶性肿瘤患者的空腹血糖和糖耐量2 h血糖均高于20~64岁中青年人(P<0.05)。结论老年人群是糖尿病和恶性肿瘤防治的重点人群。
Objective To understand the prevalence of malignant tumors in different glucose metabolism levels. Methods A stratified cluster sampling method was used to screen for diabetes in residents aged 20 and over. The chronic disease surveillance information system and regional health information platform were used to retrospectively collect information on the prevalence of malignant tumors. Results A total of 10 504 people were surveyed, 702 were newly diagnosed with diabetes mellitus, the detection rate was 6.68%. The prevalence of malignant tumors was 89, the prevalence was 8.47 ‰. The prevalence of malignant tumors in normal blood glucose, pre-diabetes and diabetic patients had no significant difference (P> 0.05). The average fasting blood glucose in patients with malignant tumor was (5.14 ± 0.65) mmol / L, and the average glucose tolerance was (6.78 ± 2.66) mmol / L. The fasting blood glucose and glucose tolerance 2 h blood glucose in patients with malignant tumors of the elderly aged 65 and above were higher than those of young people aged 20-64 (P <0.05). Conclusion The elderly population is the focus of prevention and treatment of diabetes and malignant tumors.